Sevoflurane-based anesthesia in a patient with myotonia dystrophica.
Gupta
A
A
Danielson
A
A
D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D018685:Anesthetics, Inhalation / Q000008:administration & dosage*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D000779:Anesthetics, Local / Q000008:administration & dosage; D002045:Bupivacaine / Q000008:administration & dosage; D004987:Ethers / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008614:Meperidine / Q000627:therapeutic use; D008738:Methyl Ethers; D009223:Myotonic Dystrophy / Q000150:complications* / Q000503:physiopathology; D009609:Nitrous Oxide; D010149:Postoperative Pain / Q000517:prevention & control; D015742:Propofol / Q000008:administration & dosage; D000077149:Sevoflurane; D013246:Sterilization, Tubal
D000701:Analgesics, Opioid; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D000779:Anesthetics, Local; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D008614:Meperidine; D009609:Nitrous Oxide; D002045:Bupivacaine; D015742:Propofol